These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 346436)

  • 1. beta-Alanine and gamma-aminobutyric acid contents of rat brain; post-mortem changes and effects of aminooxyacetic acid and di-n-propylacetate.
    Martin del Rio R; García-Gracia M; Orensanz Muñoz LM; DeFeudis FV
    Gen Pharmacol; 1978; 9(1):45-7. PubMed ID: 346436
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of gabaculine, a new potent inhibitor of gamma-amonobutyrate transaminase, on the brain gamma-amonobutyrate content and convulsions in mice.
    Matsui Y; Deguchi T
    Life Sci; 1977 Apr; 20(7):1291-5. PubMed ID: 850479
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of aminooxyacetic acid on in vivo gamma-aminobutyric acid system of rat oviduct.
    Martin de Rio R; López MS
    Gen Pharmacol; 1983; 14(2):281-3. PubMed ID: 6840511
    [No Abstract]   [Full Text] [Related]  

  • 4. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.
    Bernasconi R; Maitre L; Martin P; Raschdorf F
    J Neurochem; 1982 Jan; 38(1):57-66. PubMed ID: 7108535
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain gamma-aminobutyric acid and acoustic priming in C57BL/6Bg mice.
    Maxson SC; Towle AC; Sze PY
    Psychopharmacology (Berl); 1977 Aug; 53(3):217-22. PubMed ID: 408849
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of isolation-induced aggressive behavior with GABA transaminase inhibitors.
    DaVanzo JP; Sydow M
    Psychopharmacology (Berl); 1979 Mar; 62(1):23-7. PubMed ID: 108744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(5'-Phosphopyridoxyl)-4-aminobutyric acid: a stabel bisubstrate adduct inhibitor of rat brain 4-aminobutyric acid aminotransferase.
    Tunnicliff G; Ngo TT; Barbeau A
    Experientia; 1977 Jan; 33(1):20-2. PubMed ID: 836410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminooxyacetic acid: correlation between biochemical effects, anticonvulsant action and toxicity in mice.
    Löscher W; Frey HH
    Biochem Pharmacol; 1978 Jan; 27(1):103-8. PubMed ID: 619891
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices.
    Starr MS; Tanner T
    J Neurochem; 1975 Nov; 25(5):573-7. PubMed ID: 1194914
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain.
    Kukino K; Deguchi T
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2257-62. PubMed ID: 338171
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.
    Löscher W
    J Neurochem; 1980 Jun; 34(6):1603-8. PubMed ID: 7381487
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminooxyacetic acid induced changes in gamma-aminobutyrate metabolism at the subcellular level.
    Wood JD; Kurylo E; Newstead JD
    Can J Biochem; 1978 Jun; 56(6):667-72. PubMed ID: 667703
    [No Abstract]   [Full Text] [Related]  

  • 15. The uptake and release of gamma-aminobutyric acid (GABA) by the retina.
    Neal MJ
    Adv Exp Med Biol; 1976; 69():211-20. PubMed ID: 941738
    [No Abstract]   [Full Text] [Related]  

  • 16. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
    Gale K; Iadarola MJ
    Science; 1980 Apr; 208(4441):288-91. PubMed ID: 6768130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for the existence of isozymes of brain gamma-aminobutyrate aminotransferase.
    Ngo TT; Tunnicliff G
    Comp Biochem Physiol C Comp Pharmacol; 1978; 59(2):101-4. PubMed ID: 25733
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiseizure activity of gamma-acetylenic gamma-aminobutyric acid: a catalytic irreversible inhibitor of gamma-aminobutyric acid transaminase.
    Schechter PJ; Tranier Y; Jung MJ; Sjoerdsma A
    J Pharmacol Exp Ther; 1977 Jun; 201(3):606-12. PubMed ID: 864598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.
    Jung MJ; Lippert B; Metcalf BW; Schechter PJ; Böhlen P; Sjoerdsma A
    J Neurochem; 1977 Apr; 28(4):717-23. PubMed ID: 894280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.